What if a drug could kill cancer cells broadly, spare the immune system and then train it to keep fighting, without triggering resistance? That's the promise behind the ELANE pathway, a mechanism discovered not from a hypothesis but from studying fundamental biology in patients.
In this episode of the In Vivo Podcast, Court Turner, CEO and co-founder of On ... Show More
Yesterday
Drug Fix: US FDA’s Prasad Leaves, Harry Potter, And Is CNPV Effective Because Of RTOR?
Pink Sheet Executive Editor Derrick Gingery, Managing Editor Bridget Silverman and Editor-in-Chief Nielsen Hobbs discuss potential directions for the US Food and Drug Administration’s Center for Biologics Evaluation and Research after the departure of Director Vinay Prasad (:32), ... Show More
33m 45s
Dec 2024
Navigating the ESG and Sustainability Landscape Part 2
<p>As the global push for Environmental, Social, and Governance (ESG) practices and sustainability gains momentum, CFOs face the challenge of translating complex mandates into actionable strategies that simultaneously satisfy regulators, investors, and the company's bottom line.< ... Show More
27m 52s
Nov 2024
Navigating the ESG and Sustainability Landscape Part 1
<p>As the global push for ESG and sustainability gains momentum, CFOs find themselves translating complex mandates into actionable strategies that satisfy regulators, investors, and the bottom line alike.</p><p><br></p><p><a href="https://www.linkedin.com/in/marklumsdontaylor/" t ... Show More
28m 3s
Oct 2024
Weekly podcast – Is business sustainability at a tipping point?
<p style="font-weight: 400;">This week: The first in a new state-of-sustainability series, Brendan May, business expert and founder of Robertsbridge, talks with Innovation Forum’s Ian Welsh about the apparent current crossroads for sustainable business and why some companies are ... Show More
41m 5s
Jun 2025
UnitedHealth Group: Beyond The Premium - [Business Breakdowns, EP.219]
This is Zack Fuss. Today, we're tackling a giant in a controversial and incredibly complex industry, UnitedHealth Group. At its recent apex, UNH was a half-trillion-dollar market cap business, the 15th largest listed business in the United States. Today, that market cap sits at j ... Show More
1h 4m